Neurocognitive Analysis of Low-level Arsenic Exposure and Executive Function Mediated by Brain Anomalies Among Children, Adolescents, and Young Adults in India
-
- Nilakshi Vaidya
- Centre for Population Neuroscience and Precision Medicine, Department of Psychiatry and Neuroscience, Charité Universitätsmedizin Berlin, Berlin, Germany
-
- Bharath Holla
- Department of Psychiatry and Integrative Medicine, National Institute of Mental Health and Neurosciences, Bangalore, India
-
- Jon Heron
- Centre for Public Health, Bristol Medical School, University of Bristol, Bristol, United Kingdom
-
- Eesha Sharma
- Department of Child & Adolescent Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India
-
- Yuning Zhang
- Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, United Kingdom
-
- Gwen Fernandes
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
-
- Udita Iyengar
- Institute of Psychology, Psychiatry & Neuroscience, King’s College London, London, United Kingdom
-
- Alex Spiers
- MRC (Medical Research Council) Centre for Environment and Health, Imperial College London, London, United Kingdom
-
- Anupa Yadav
- Indian Council of Medical Research–Centre for Ageing and Mental Health, Kolkata, India
-
- Surajit Das
- Indian Council of Medical Research–Centre for Ageing and Mental Health, Kolkata, India
-
- Sanjit Roy
- Indian Council of Medical Research–Centre for Ageing and Mental Health, Kolkata, India
-
- Chirag K. Ahuja
- Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research, Chandigarh, India
-
- Gareth J. Barker
- Department of Neuroimaging, Institute of Psychology, Psychiatry & Neuroscience, King’s College London, London, United Kingdom
-
- Debasish Basu
- Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India
-
- Rose Dawn Bharath
- Department of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neurosciences, Bangalore, India
-
- Matthew Hickman
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
-
- Sanjeev Jain
- Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India
-
- Kartik Kalyanram
- Rishi Valley, Rural Health Centre, India
-
- Kamakshi Kartik
- Rishi Valley, Rural Health Centre, India
-
- Murali Krishna
- Foundation for Research and Advocacy in Mental Health, Mysore, India
-
- Ghattu Krishnaveni
- Epidemiology Research Unit, CSI Holdsworth Memorial Hospital, Mysore, India
-
- Kalyanaraman Kumaran
- Epidemiology Research Unit, CSI Holdsworth Memorial Hospital, Mysore, India
-
- Rebecca Kuriyan
- Division of Nutrition, St John’s Research Institute, Bangalore, India
-
- Pratima Murthy
- Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India
-
- Dimitri Papadopoulos Orfanos
- NeuroSpin, Commissariat à l’Énergie Atomique et aux Énergies Alternatives, Université Paris-Saclay, Paris, France
-
- Meera Purushottam
- Molecular Genetics Laboratory, National Institute of Mental Health and Neurosciences, Bangalore, India
-
- Sunita Simon Kurpad
- Department of Psychiatry, St John’s Medical College and Hospital, Bangalore, India
-
- Lenin Singh
- Regional Institute of Medical Sciences, Imphal, Manipur, India
-
- Roshan Singh
- Regional Institute of Medical Sciences, Imphal, Manipur, India
-
- B. N. Subodh
- Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India
-
- Mireille Toledano
- MRC (Medical Research Council) Centre for Environment and Health, Imperial College London, London, United Kingdom
-
- Henrik Walter
- Psychiatry, Psychiatric Neuroscience and Neurophilosophy, Research Division of Mind and Brain, Charité-Universitätsmedizin Berlin, Berlin, Germany
-
- Sylvane Desrivières
- Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, United Kingdom
-
- Amit Chakrabarti
- Indian Council of Medical Research–Centre for Ageing and Mental Health, Kolkata, India
-
- Vivek Benegal
- Centre for Addiction Medicine, National Institute of Mental Health and Neurosciences, Bangalore, India
-
- Gunter Schumann
- Centre for Population Neuroscience and Precision Medicine, Department of Psychiatry and Neuroscience, Charité Universitätsmedizin Berlin, Berlin, Germany
-
- Mathew Varghese
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Kandavel Thennarasu
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Urvakhsh Metha
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Satish Girimaji
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Preeti Jacob
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Deepak Jayarajan
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Keshav Kumar
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Gitanjali Narayanan
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Madhu Khullar
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Niranjan Khandelwal
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Abhishek Ghosh
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Nainesh Joshi
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Ningthoujam Debala Chanu
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Fujica M.C.
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Victoria Ph.
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Celina Phurailatpam
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Debangana Bhattacharya
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Bidisha Haque
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Alisha Nagraj
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Arpita Ghosh
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Anirban Basu
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Mriganka Pandit
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Subhadip Das
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Pawan Maurya
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Amritha Gourisankar
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Geetha Rani T
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Sujatha B
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Madhavi Rangaswamy
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Caroline Fall
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Kiran KN
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Ramya MC
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Chaitra Urs
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Santhosh N
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Somashekhara R
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Divyashree K
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Arathi Rao
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Poornima R
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Saswathika Tripathy
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Neha Parashar
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Nayana K B
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Ashwini Seshadri
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Sathish Kumar
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Suneela Baligar
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Thamodaran Arumugam
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Apoorva Safai
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Anthony Cyril
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Ashika Roy
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Dhanalakshmi D
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Shivamma D
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
-
- Bhavana B R
- for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
Description
<jats:sec id="ab-zoi230394-4"><jats:title>Importance</jats:title><jats:p>Arsenic, a contaminant of groundwater and irrigated crops, is a global public health hazard. Exposure to low levels of arsenic through food extends well beyond the areas with high arsenic content in water.</jats:p></jats:sec><jats:sec id="ab-zoi230394-5"><jats:title>Objective</jats:title><jats:p>To identify cognitive impairments following commonly prevalent low-level arsenic exposure and characterize their underlying brain mechanisms.</jats:p></jats:sec><jats:sec id="ab-zoi230394-6"><jats:title>Design, Setting, and Participants</jats:title><jats:p>This multicenter population-based cohort study analyzed cross-sectional data of the Indian Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA) cohort, recruited between November 4, 2016, and May 4, 2019. Participants aged 6 to 23 years were characterized using deep phenotyping measures of behavior, neuropsychology, psychopathology, brain neuroimaging, and exposure to developmental adversities and environmental neurotoxins. All analyses were performed between June 1, 2020, and December 31, 2021.</jats:p></jats:sec><jats:sec id="ab-zoi230394-7"><jats:title>Exposure</jats:title><jats:p>Arsenic levels were measured in urine as an index of exposure.</jats:p></jats:sec><jats:sec id="ab-zoi230394-8"><jats:title>Main Outcomes and Measures</jats:title><jats:p>Executive function measured using the cVEDA neuropsychological battery, gray matter volume (GMV) from T1-weighted magnetic resonance imaging, and functional network connectivity measures from resting state functional magnetic resonance imaging.</jats:p></jats:sec><jats:sec id="ab-zoi230394-9"><jats:title>Results</jats:title><jats:p>A total of 1014 participants aged 6 to 23 years (589 male [58.1%]; mean [SD] age, 14.86 [4.79] years) were included from 5 geographic locations. Sparse-partial least squares analysis was used to describe a negative association of arsenic exposure with executive function (<jats:italic>r</jats:italic> = −0.12 [<jats:italic>P</jats:italic> = 5.4 × 10<jats:sup>−4</jats:sup>]), brain structure (<jats:italic>r</jats:italic> = −0.20 [<jats:italic>P</jats:italic> = 1.8 × 10<jats:sup>−8</jats:sup>]), and functional connectivity (within network, <jats:italic>r</jats:italic> = −0.12 [<jats:italic>P</jats:italic> = 7.5 × 10<jats:sup>−4</jats:sup>]; between network, <jats:italic>r</jats:italic> = −0.23 [<jats:italic>P</jats:italic> = 1.8 × 10<jats:sup>−10</jats:sup>]). Alterations in executive function were partially mediated by GMV (<jats:italic>b</jats:italic> = −0.004 [95% CI, −0.007 to −0.002]) and within-network functional connectivity (<jats:italic>b</jats:italic> = −0.004 [95% CI, −0.008 to −0.002]). Socioeconomic status and body mass index moderated the association between arsenic and GMV, such that the association was strongest in participants with lower socioeconomic status and body mass index.</jats:p></jats:sec><jats:sec id="ab-zoi230394-10"><jats:title>Conclusions and Relevance</jats:title><jats:p>The findings of this cross-sectional study suggest that low-level arsenic exposure was associated with alterations in executive functioning and underlying brain correlates. These results indicate potential detrimental consequences of arsenic exposure that are below the currently recommended guidelines and may extend beyond endemic risk areas. Precision medicine approaches to study global mental health vulnerabilities highlight widespread but potentially modifiable risk factors and a mechanistic understanding of the impact of low-level arsenic exposure on brain development.</jats:p></jats:sec>
Journal
-
- JAMA Network Open
-
JAMA Network Open 6 (5), e2312810-, 2023-05-12
American Medical Association (AMA)
- Tweet
Details 詳細情報について
-
- CRID
- 1360021395962059264
-
- ISSN
- 25743805
-
- Data Source
-
- Crossref